Endothelin-1 in atherosclerosis and other vasculopathies

Area of Science:

• Cardiovascular Science
• Molecular Biology
• Pathophysiology

Background:

• Atherosclerosis is a primary risk factor for myocardial infarction and stroke.
• Vasoactive factor imbalance is central to atherosclerotic disease progression.
• Endothelin-1 (ET-1) is a key vasoactive peptide implicated in vascular dysfunction.

Purpose of the Study:

• To review the role of endothelin-1 in the atherosclerotic process.
• To explore ET-1's involvement in other vasculopathies.
• To discuss the regulation and physiological activities of ET-1 in the cardiovascular system.

Main Methods:

• Review of existing literature on endothelin-1 and atherosclerosis.
• Analysis of studies demonstrating correlation between ET-1 expression and atherosclerotic lesions.
• Examination of immunoreactivity for ET-1 and its converting enzyme (ECE-1) in vascular cells within lesions.

Main Results:

• A correlation exists between endothelin expression and atherosclerotic lesions.
• Immunoreactivity for ET-1 and ECE-1 is found in endothelial cells, smooth muscle cells, and macrophages within atherosclerotic lesions.
• ET-1 exhibits vasoconstriction, mitogenesis, promotes neutrophil adhesion and platelet aggregation, induces hypertrophy, and generates reactive oxygen species.

Conclusions:

• Endothelin-1 is integral to the atherosclerotic process and various vasculopathies.
• ET-1's diverse physiological activities, including ROS generation, underscore its pathogenic role.
• Regulation of ET-1 by factors like angiotensin II, aging, and LDL is critical in cardiovascular health.